Favorable impact of the t(9;11) in childhood acute myeloid leukemia

Journal of Clinical Oncology

Volumn 20, Issue 9, 2002, Pages 2302-2309

  Rubnitz, Jeffrey E ^a   Raimondi, Susana C ^a   Tong, Xin ^a   Kumar Srivastava, Deo ^a   Razzouk, Bassem I ^a   Shurtleff, Sheila A ^a   Downing, James R ^a   Pui, Ching Hon ^a   Ribeiro, Raul C ^a   Behm, Frederick G ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 11Q; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 9; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; HUMAN; INFANT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SURVIVAL TIME;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; FEMALE; GENE REARRANGEMENT; HUMANS; INFANT; LEUKEMIA, MYELOID; MALE; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 20244389694     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.08.400     Document Type: Article

References (32)

1. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial - The Medical Research Council Adult and Children's Leukaemia Working Parties
2. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype
3. Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a cooperative Pediatric Oncology Group study-POG 8821
4. Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): Univariate and recursive partitioning
5. Patients with t(8;21)(q22; q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered
6. Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: A Cancer and Leukemia Group B study
7. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia
8. Translocation t(9; 11)(p21;q23) in pediatric de novo and secondary acute myeloblastic leukemia
9. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo
10. Prognostic factors in infants with acute myeloid leukemia
11. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission
12. Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: Improved remission induction with a five-drug regimen including etoposide
13. Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: Short-and long-term effects
14. Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases
15. A direct bone marrow chromosome technique for acute lymphoblastic leukemia
16. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age
17. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8; 21)(q22;q22) translocation
18. Biology and outcome of childhood acute megakaryoblastic leukemia: A single institution's experience
19. Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: A single institution's experience
20. Hematological malignancies with t(9;11)(p21-22;q23): A laboratory and clinical study of 125 cases - European 11q23 Workshop participants
21. Acute monoblastic leukemia in infancy and early childhood: Successful treatment with an epipodophyllotoxin
22. Acute monocytic leukemia in children: Response to VP-16-213 as a single agent
23. Topoisomerase II inhibitor-related acute myeloid leukaemia
24. Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalities
25. The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene
26. A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia
27. MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): Both rearrangements are associated with a poor prognosis
28. AF10 is split by MLL and HEAB, a human homolog to a putative Caenorhabditis elegans ATP/GTP-binding protein in an invins(10; 11)(p12:q23q12)
29. Molecular analysis of the CALM/AF10 fusion: Identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients
30. Identification and molecular characterization of CALM/AF10 fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia
31. AB1-1, a human homolog to mouse Ab1-interacter 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23)
32. The t(10;11)(p12; q23) translocation in acute leukaemia: A cytogenetic and clinical study of 20 patients - European 11q23 Workshop PARTicipants